Background: Home oxygen therapy is often required in children with chronic respiratory conditions. This document provides an evidence-based clinical practice guideline on the implementation, monitoring, and discontinuation of home oxygen therapy for the pediatric population. Methods: A multidisciplinary panel identified pertinent questions regarding home oxygen therapy in children, conducted systematic reviews of the relevant literature, and applied the Grading of Recommendations, Assessment, Development, and Evaluation approach to rate the quality of evidence and strength of clinical recommendations. Results: After considering the panel’s confidence in the estimated effects, the balance of desirable (benefits) and undesirable (harms and burdens) consequences of treatment, patient values and preferences, cost, and feasibility, recommendations were developed for or against home oxygen therapy specific to pediatric lung and pulmonary vascular diseases. Conclusions: Although home oxygen therapy is commonly required in the care of children, there is a striking lack of empirical evidence regarding implementation, monitoring, and discontinuation of supplemental oxygen therapy. The panel formulated and provided the rationale for clinical recommendations for home oxygen therapy based on scant empirical evidence, expert opinion, and clinical experience to aid clinicians in the management of these complex pediatric patients and identified important areas for future research.
1 September 2017 in Annals of the American Thoracic Society
Rationale: Tracheobronchomalacia (TBM) is a common comorbidity in neonates with bronchopulmonary dysplasia (BPD). However, the effect of TBM on the clinical course of BPD is not well understood. Objectives: We sought to assess the impact of TBM on outcomes in neonates with BPD in a large, multicenter cohort. Methods: We performed a cohort study of 974 neonates with BPD admitted to 27 neonatal intensive care units participating in the Children’s Hospital Neonatal Database who had undergone bronchoscopy. In-hospital morbidity for neonates with BPD and TBM (n = 353, 36.2%) was compared with those without TBM (n = 621, 63.8%) using mixed-effects multivariate regression. Results: Neonates with TBM and BPD had more comorbidities, such as gastroesophageal reflux (odds ratio [OR], 1.65; 95% confidence interval [CI], 1.23–2.29; P = 0.001) and pneumonia (OR, 1.68; 95% CI, 1.21–2.33; P = 0.002), and more commonly required surgeries, such as tracheostomy (OR, 1.55; 95% CI, 1.15–2.11; P = 0.005) and gastrostomy (OR, 1.38; 95% CI: 1.03–1.85; P = 0.03), than those without TBM. Neonates with TBM were hospitalized (118 ± 93 d vs. 105 ± 83 d; P = 0.02) and ventilated (83.1 ± 91.1 d vs. 67.2 ± 71.9 d; P = 0.003) longer than those without TBM. On discharge, neonates with TBM and BPD were more likely to be mechanically ventilated (OR, 1.37; 95% CI, 1.01–1.87; P = 0.045) and possibly less likely to receive oral nutrition (OR, 0.69; 95% CI, 0.47–1.01; P = 0.058). Conclusions: TBM is common in neonates with BPD who undergo bronchoscopy and is associated with longer and more complicated hospitalizations.
15 December 2021 in American Journal of Respiratory and Critical Care Medicine
Background: Premature birth affects millions of neonates each year, placing them at risk for respiratory disease due to prematurity. Bronchopulmonary dysplasia is the most common chronic lung disease of infancy, but recent data suggest that even premature infants who do not meet the strict definition of bronchopulmonary dysplasia can develop adverse pulmonary outcomes later in life. This post-prematurity respiratory disease (PPRD) manifests as chronic respiratory symptoms, including cough, recurrent wheezing, exercise limitation, and reduced pulmonary function. This document provides an evidence-based clinical practice guideline on the outpatient management of infants, children, and adolescents with PPRD. Methods: A multidisciplinary panel of experts posed questions regarding the outpatient management of PPRD. We conducted a systematic review of the relevant literature. The Grading of Recommendations, Assessment, Development, and Evaluation approach was used to rate the quality of evidence and the strength of the clinical recommendations. Results: The panel members considered the strength of each recommendation and evaluated the benefits and risks of applying the intervention. In formulating the recommendations, the panel considered patient and caregiver values, the cost of care, and feasibility. Recommendations were developed for or against three common medical therapies and four diagnostic evaluations in the context of the outpatient management of PPRD. Conclusions: The panel developed recommendations for the outpatient management of patients with PPRD on the basis of limited evidence and expert opinion. Important areas for future research were identified.
With improved survival rates, short- and long-term respiratory complications of premature birth are increasing, adding significantly to financial and health burdens in the United States. In response, in May 2010, the National Institutes of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) funded a 5-year $18.5 million research initiative to ultimately improve strategies for managing the respiratory complications of preterm and low birth weight infants. Using a collaborative, multi-disciplinary structure, the resulting Prematurity and Respiratory Outcomes Program (PROP) seeks to understand factors that correlate with future risk for respiratory morbidity. The PROP is an observational prospective cohort study performed by a consortium of six clinical centers (incorporating tertiary neonatal intensive care units [NICU] at 13 sites) and a data-coordinating center working in collaboration with the NHLBI. Each clinical center contributes subjects to the study, enrolling infants with gestational ages 23 0/7 to 28 6/7 weeks with an anticipated target of 750 survivors at 36 weeks post-menstrual age. In addition, each center brings specific areas of scientific focus to the Program. The primary study hypothesis is that in survivors of extreme prematurity specific biologic, physiologic and clinical data predicts respiratory morbidity between discharge and 1 year corrected age. Analytic statistical methodology includes model-based and non-model-based analyses, descriptive analyses and generalized linear mixed models. PROP incorporates aspects of NICU care to develop objective biomarkers and outcome measures of respiratory morbidity in the <29 week gestation population beyond just the NICU hospitalization, thereby leading to novel understanding of the nature and natural history of neonatal lung disease and of potential mechanistic and therapeutic targets in at-risk subjects. Clinical Trials.gov NCT01435187 .
This is a summary of the presentation on the pathophysiology of respiratory impairment in pediatric neuromuscular disorders presented as part of the program on pulmonary management of pediatric patients with neuromuscular disease at the 30th annual Carrell-Krusen Neuromuscular Symposium on February 20, 2008.